Spirocard
Tablet
Generic Name
Spironolactone
Manufacturer
Popular Pharmaceuticals Ltd.
Unit Price
Unit Price: ৳ 20.00 (3 x 10: ৳ 600.00) Strip Price: ৳ 200.00
🔹 Indications
Spirocard tablet is indicated for the management of oedema and ascites in cirrhosis of the liver, malignant ascites, nephrotic syndrome, congestive heart failure and primary hyperaldosteronism.
🔹 Pharmacology
Spirocard tablet is indicated for the management of oedema and ascites in cirrhosis of the liver, malignant ascites, nephrotic syndrome, congestive heart failure and primary hyperaldosteronism.
🔹 Dosage & Administration
Spirocard tablet is indicated for the management of oedema and ascites in cirrhosis of the liver, malignant ascites, nephrotic syndrome, congestive heart failure and primary hyperaldosteronism.
🔹 Interaction
Spirocard tablet is indicated for the management of oedema and ascites in cirrhosis of the liver, malignant ascites, nephrotic syndrome, congestive heart failure and primary hyperaldosteronism.
🔹 Contraindications
Spirocard tablet is indicated for the management of oedema and ascites in cirrhosis of the liver, malignant ascites, nephrotic syndrome, congestive heart failure and primary hyperaldosteronism.
🔹 Side Effects
Spirocard tablet is indicated for the management of oedema and ascites in cirrhosis of the liver, malignant ascites, nephrotic syndrome, congestive heart failure and primary hyperaldosteronism.
🔹 Pregnancy & Lactation
Spirocard tablet is indicated for the management of oedema and ascites in cirrhosis of the liver, malignant ascites, nephrotic syndrome, congestive heart failure and primary hyperaldosteronism.
🔹 Precautions & Warnings
Spirocard tablet is indicated for the management of oedema and ascites in cirrhosis of the liver, malignant ascites, nephrotic syndrome, congestive heart failure and primary hyperaldosteronism.
🔹 Storage Conditions
Spirocard tablet is indicated for the management of oedema and ascites in cirrhosis of the liver, malignant ascites, nephrotic syndrome, congestive heart failure and primary hyperaldosteronism.
💡 Frequently Asked Questions
Spirocard tablet is indicated for the management of oedema and ascites in cirrhosis of the liver, malignant ascites, nephrotic syndrome, congestive heart failure and primary hyperaldosteronism.
Spirocard tablet is indicated for the management of oedema and ascites in cirrhosis of the liver, malignant ascites, nephrotic syndrome, congestive heart failure and primary hyperaldosteronism.
Spirocard tablet is indicated for the management of oedema and ascites in cirrhosis of the liver, malignant ascites, nephrotic syndrome, congestive heart failure and primary hyperaldosteronism.
User Reviews
⭐
No reviews yet!
Be the first to share your experience.